SEC Form 4 · accession 0001209191-18-015546
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susanna Gatti High
Officer — Chief Operating Officer
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2018 | M | 1,044 | $68.65 | A | 18,544 | D | |
| Common StockF2 | Feb 28, 2018 | S | 400 | $202.10 | D | 18,144 | D | |
| Common StockF3 | Feb 28, 2018 | S | 644 | $203.0312 | D | 17,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $68.65 | Feb 28, 2018 | M | 1,044 | D | — | Dec 1, 2026 | Common Stock | 1,044 | 44,162 | D |
Explanation of responses
- F1This sales reported in the Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 18, 2017.
- F2The range in prices for the transaction reported on this line was $201.75 to $202.60. The average weighted price was $202.10. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $202.90 to $203.2750. The average weighted price was $203.0312. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4This option vests over a four-year period at a rate of twenty-five percent (25%) on November 30, 2017, and in 36 equal monthly installments thereafter.